Your browser doesn't support javascript.
loading
Half-Life Extended Nanobody-Based CD38-Specific Bispecific Killercell Engagers Induce Killing of Multiple Myeloma Cells.
Hambach, Julia; Fumey, William; Stähler, Tobias; Gebhardt, Anna Josephine; Adam, Gerhard; Weisel, Katja; Koch-Nolte, Friedrich; Bannas, Peter.
Afiliación
  • Hambach J; Institute of Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Fumey W; Department of Diagnostic and Interventional Radiology and Nuclear Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Stähler T; Institute of Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Gebhardt AJ; Department of Diagnostic and Interventional Radiology and Nuclear Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Adam G; Institute of Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Weisel K; Institute of Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Koch-Nolte F; Department of Diagnostic and Interventional Radiology and Nuclear Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Bannas P; Department of Diagnostic and Interventional Radiology and Nuclear Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Front Immunol ; 13: 838406, 2022.
Article en En | MEDLINE | ID: mdl-35651607
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Anticuerpos de Dominio Único / Mieloma Múltiple Límite: Humans Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Anticuerpos de Dominio Único / Mieloma Múltiple Límite: Humans Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Suiza